HK Stock Market Move | CANSINOBIO (06185) falls more than 6% during trading hours, with a nearly 40% year-on-year increase in revenue in the first quarter. Net loss expands 2.5 times.

date
11:42 29/04/2026
avatar
GMT Eight
CanSino Biologics (06185) fell more than 6% intraday, as of the time of writing, it is down 4.81% at HK$30.5, with a turnover of HK$46.409 million.
CANSINOBIO (06185) fell more than 6% during the trading day, dropping 4.81% by the time of writing to 30.5 Hong Kong dollars, with a turnover of 46.4069 million Hong Kong dollars. On the news front, CANSINOBIO released its performance for the three months ended March 31, 2026, with operating income of 190 million yuan, a year-on-year increase of 38.73%; a net loss attributable to shareholders of the listed company of 40.4243 million yuan, a year-on-year increase of 250.13%. The company stated that the revenue growth was mainly due to the expansion of the commercial product matrix and the gradual increase in overseas market volume. In addition, profit pressure is mainly attributed to the increase in operating costs, sales, management, and research and development expenses driven by revenue growth, as well as a decrease in other income related to government special subsidies and international special funds, combined with the impact of adjustments in value-added tax policies.